American Well 3Q 2026: Revenue $49M, Net loss $11.4M, EPS ($0.67) — 10-Q Summary

American Well reported 3Q 2026 revenue of $49M, down 13% YoY, with net loss narrowing to $11.4M. EPS was ($0.67). Nine-month revenue fell 20%, with platform visits decreasing. The company divested its APC business to focus on profitability and digital care adoption. According to the company, it is pursuing cost efficiencies.

Original reporting
Published Nov 3, 2026, 9:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 6:26 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
American Well 3Q 2026: Revenue $49M, Net loss $11.4M, EPS ($0.67) — 10-Q Summary — source image
Decision brief

The 30-second read

$AMWLNeutralMed
01

Why it matters

Traders can reassess near-term fundamentals using the reported quarterly financials and the strategic shift away from APC, but there is no explicit forward guidance in the text.

02

Market read

A fresh quarterly print with improving losses but declining revenue, plus a portfolio change, can drive re-rating for profitability trajectory versus growth concerns.

03

What to watch

Platform visit metrics and provider mix improved (provider-performed visits share up), which could indicate engagement gains that may take time to translate into subscription revenue.

Relevance 7/10Novelty 7/10Timing: after-hours/filing day, based on Nov. 3, 2026 10-Q summary

Background

The piece summarizes American Well’s 3Q 2026 Form 10-Q, including revenue, net loss, EPS, and business highlights such as APC divestiture and platform adoption commentary.

Company-level read

Ticker impact

$AMWLNeutralMedium confidence
Context

American Well reported 3Q 2026 revenue of $49M (down 13% YoY) and narrowed net loss to $11.4M, plus APC business divestiture.

Expected impact

Likely mixed reaction, with loss narrowing supportive but revenue decline and limited growth signals tempering upside.

Evidence & confidence

The article provides fresh quarterly financial datapoints and a specific business divestiture, but no guidance or explicit turnaround inflection beyond efficiency and adoption commentary.

Market effects

Reinforces ongoing pressure on digital health platforms’ top-line growth while cost actions can stabilize losses.

No clear regional spillover beyond US-listed digital health sentiment.

Limited, as the disclosure is company-specific and not tied to global macro or regulation.

Counterpoint

Loss narrowing may reflect one-time expense reductions rather than durable operating leverage, so revenue weakness could reassert quickly.

Key entities

  • American Well Corporation

    Digital health platform company reporting 3Q 2026 revenue decline, narrowed net loss, and APC business divestiture.

Related articles

$AMWLMed

American Well Corp (AMWL) Q3 2026 Earnings Call Highlights: Revenue Beat, Raised Guidance

American Well Corp (AMWL) reported Q3 2026 revenue of $49M, down 12.9% YoY. Subscription revenue fell 22.5% due to churn. Platform visits dropped 30.5% YoY. The VA letter of intent is non-binding, and the DHA contract conversion is pending. CEO Dr. Ido Schoenberg expressed optimism about negotiations and potential growth opportunities. The company expects Q4 adjusted EBITDA breakeven and raised guidance.

$AMWLMedAI 8/10

What American Well (AMWL) Said on Its Q3 Earnings Call

Amwell (AMWL) reported Q3 earnings with virtual primary care visits up 41% YoY, but total platform visits down 30.5%. Gross profit was $26M with a 53% margin. Q4 revenue is forecasted at $48M-$50M, with adjusted EBITDA expected to break even or turn positive. The company raised its full-year 2026 outlook, now expecting revenue of $204M-$206M and a reduced adjusted EBITDA loss. Amwell also discussed potential government contracts, including a nonbinding letter of intent from the VA.

$AMWLHigh

American Well Corp (AMWL): AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE third QUARTER 2026 BOSTON, November 3 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30,

$AMWLMedAI 8/10

American Well (AMWL) Q2 2026 Earnings Call Transcript

American Well (AMWL) reported Q2 2026 revenue of $52 million, down 26.6% year over year, with subscription revenue of $25.7 million and AMG revenue of $24.4 million. Adjusted EBITDA loss was $1.15 million and net loss was $9.6 million. Full-year guidance was narrowed to $200-$205 million revenue and improved adjusted EBITDA loss to $9-$7 million. The Defense Health Agency issued an intent to award a sole-source contract.

$AMWLMed

American Well Corp (AMWL): AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026

American Well Corp (AMWL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMWELL® ANNOUNCES RESULTS FOR THE Second QUARTER 2026 BOSTON, August 4 , 2026 –Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30, 2026